Analysts predict that Aetna Inc (NYSE:AET) will announce sales of $15.24 billion for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Aetna’s earnings. The lowest sales estimate is $15.04 billion and the highest is $15.45 billion. Aetna posted sales of $14.95 billion in the same quarter last year, which suggests a positive year over year growth rate of 1.9%. The company is scheduled to report its next earnings report before the market opens on Tuesday, October 30th.
On average, analysts expect that Aetna will report full year sales of $61.33 billion for the current financial year, with estimates ranging from $60.77 billion to $61.98 billion. For the next fiscal year, analysts forecast that the business will post sales of $64.68 billion, with estimates ranging from $63.79 billion to $65.66 billion. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that that provide coverage for Aetna.
Aetna (NYSE:AET) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $3.43 earnings per share for the quarter, beating analysts’ consensus estimates of $3.04 by $0.39. Aetna had a net margin of 5.77% and a return on equity of 20.66%. The business had revenue of $15.56 billion during the quarter, compared to analysts’ expectations of $15.59 billion. During the same period last year, the business earned $3.42 earnings per share. The business’s revenue for the quarter was up .2% on a year-over-year basis.
Several hedge funds and other institutional investors have recently bought and sold shares of AET. Kaizen Advisory LLC boosted its stake in shares of Aetna by 143.9% in the second quarter. Kaizen Advisory LLC now owns 766 shares of the company’s stock valued at $141,000 after purchasing an additional 452 shares during the period. Clearwater Capital Advisors LLC purchased a new position in shares of Aetna in the first quarter valued at approximately $154,000. CSat Investment Advisory L.P. purchased a new position in shares of Aetna in the second quarter valued at approximately $162,000. Mainstay Capital Management LLC ADV boosted its stake in shares of Aetna by 1,696.3% in the second quarter. Mainstay Capital Management LLC ADV now owns 11,209 shares of the company’s stock valued at $162,000 after purchasing an additional 10,585 shares during the period. Finally, Sun Life Financial INC boosted its stake in shares of Aetna by 252.0% in the second quarter. Sun Life Financial INC now owns 887 shares of the company’s stock valued at $163,000 after purchasing an additional 635 shares during the period. 83.49% of the stock is owned by institutional investors and hedge funds.
Shares of AET traded down $0.58 during trading on Tuesday, reaching $203.72. 898,587 shares of the company traded hands, compared to its average volume of 2,145,427. Aetna has a twelve month low of $149.69 and a twelve month high of $206.66. The stock has a market cap of $66.41 billion, a PE ratio of 20.66, a P/E/G ratio of 1.74 and a beta of 0.69. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.74 and a quick ratio of 0.74.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 1st. Stockholders of record on Wednesday, October 24th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.98%. The ex-dividend date of this dividend is Tuesday, October 23rd. Aetna’s payout ratio is 20.28%.
Aetna Inc operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis.
Read More: Trading Strategy
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.